BCCOY (BICO Group AB) FCF Margin % : 28.40% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BICO Group AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BICO Group AB's Free Cash Flow for the three months ended in Dec. 2024 was $14.8 Mil. BICO Group AB's Revenue for the three months ended in Dec. 2024 was $52.0 Mil. Therefore, BICO Group AB's FCF Margin % for the quarter that ended in Dec. 2024 was 28.40%.

As of today, BICO Group AB's current FCF Yield % is 4.46%.

The historical rank and industry rank for BICO Group AB's FCF Margin % or its related term are showing as below:

BCCOY' s FCF Margin % Range Over the Past 10 Years
Min: -112.6 Med: -51.34 Max: 3.96
Current: 3.96

During the past 9 years, the highest FCF Margin % of BICO Group AB was 3.96%. The lowest was -112.60%. And the median was -51.34%.

BCCOY's FCF Margin % is ranked better than
64.48% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -3.47 vs BCCOY: 3.96

BICO Group AB FCF Margin % Historical Data

The historical data trend for BICO Group AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB FCF Margin % Chart

BICO Group AB Annual Data

Trend

Aug16

Aug17

Aug18

Aug19

Aug20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-87.18

-53.78

-37.67

-5.61

3.74

BICO Group AB Quarterly Data
	Nov19	Feb20	May20	Aug20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															24.08	-6.47	-13.78	6.94	28.40

Competitive Comparison of BICO Group AB's FCF Margin %

For the Medical Devices subindustry, BICO Group AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BICO Group AB's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BICO Group AB's FCF Margin % falls into.

Save Embed

;

Save Embed

;

BICO Group AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BICO Group AB's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	6.618	/	177.178
	=	3.74 %

BICO Group AB's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	14.757	/	51.962
	=	28.40 %

BICO Group AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of BICO Group AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BICO Group AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (OTCPK:BCCOY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CLLKF:USA BICO:Sweden 49Z:Germany

Address

Langfilsgatan 9, Gothenburg, SWE, 41277

Website

https://www.bico.com

BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).